26
Jun
Jun
This is history in the making. For the first time ever, the Federal Drug Administration approved a drug featuring an active component from cannabis. Epidiolex, which has been in Stage 3 testing since 2015, is now approved as a prescription treatment for two rare and lethal forms of epilepsy: Dravet’s and Lennox-Gastaut Syndrome. Finally, the […]
